Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma
- PMID: 6209008
Phase II trial of vinblastine, bleomycin, and cisplatin (VBP) followed by dacarbazine and mitolactol in metastatic melanoma
Similar articles
-
A phase II trial of vinblastine, bleomycin, and cisplatin induction followed by dacarbazine and dibromodulcitol maintenance in the treatment of metastatic melanoma. A follow-up study of twenty-two patients.Am J Clin Oncol. 1988 Dec;11(6):666-8. doi: 10.1097/00000421-198812000-00016. Am J Clin Oncol. 1988. PMID: 2461074
-
Cisplatin, vinblastine, and bleomycin in the treatment of metastatic melanoma: a phase II study of the Southeastern Cancer Study Group.Cancer Treat Rep. 1985 Jul-Aug;69(7-8):821-4. Cancer Treat Rep. 1985. PMID: 2410120
-
Treatment of metastatic malignant melanoma with dacarbazine and cisplatin.Cancer Treat Rep. 1987 Sep;71(9):877-8. Cancer Treat Rep. 1987. PMID: 3621224 No abstract available.
-
[Chemotherapy of malignant melanoma].Gan To Kagaku Ryoho. 1995 Jan;22(1):23-7. Gan To Kagaku Ryoho. 1995. PMID: 7529980 Review. Japanese.
-
Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.Semin Oncol. 1994 Dec;21(6 Suppl 14):23-8. Semin Oncol. 1994. PMID: 7992096 Review.
Cited by
-
Phase II study of AMSA alone and in combination with DTIC in patients with metastatic melanoma.Invest New Drugs. 1988 Apr;6(1):57-61. doi: 10.1007/BF00170782. Invest New Drugs. 1988. PMID: 3410667 Clinical Trial.
-
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma.J Cancer Res Clin Oncol. 1989;115(1):93-5. doi: 10.1007/BF00391607. J Cancer Res Clin Oncol. 1989. PMID: 2466036 Free PMC article.
Publication types
MeSH terms
Substances
Supplementary concepts
LinkOut - more resources
Medical